Ledger.Open graph →
SEC Form D · filed May 10, 2024

Bluejay Therapeutics, Inc

Offering
$182.0M
Sold
$182.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
SAN MATEO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Dan Estes · Menlo Park, CADirectorPascal Krotee · SAN MATEO, CADirectorJianqing Li · SAN MATEO, CADirectorKeting Chu · Hong Kong, Hong KongExec · DirectorAlon Lazarus · Cambridge, MADirectorDajun Yang · Rockville, MDDirectorDan Estes · Menlo Park, CADirectorPascal Krotee · SAN MATEO, CADirectorJianqing Li · SAN MATEO, CADirectorKeting Chu · Hong Kong, Hong KongExec · DirectorAlon Lazarus · Cambridge, MADirectorDajun Yang · Rockville, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗